NYSE:ATHAthene Stock Price, Forecast & News

Athene's stock was trading at $31.16 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ATH stock has decreased by 14.6% and is now trading at $26.60. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Athene.

Athene is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Athene.

Athene Holding Ltd (NYSE:ATH) issued its quarterly earnings data on Tuesday, February, 18th. The insurance provider reported $2.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.68 by $0.53. The insurance provider earned $1.23 billion during the quarter, compared to analyst estimates of $1.28 billion. Athene had a net margin of 13.50% and a return on equity of 10.56%. The company's revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $1.23 EPS. View Athene's earnings history.

10 Wall Street analysts have issued 1 year price objectives for Athene's shares. Their forecasts range from $32.00 to $68.00. On average, they anticipate Athene's stock price to reach $47.20 in the next twelve months. This suggests a possible upside of 77.4% from the stock's current price. View analysts' price targets for Athene.

Media headlines about ATH stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Athene earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the insurance provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutAthene.

Athene saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 7,731,700 shares, an increase of 91.4% from the February 27th total of 4,040,000 shares. Based on an average trading volume of 1,610,000 shares, the days-to-cover ratio is presently 4.8 days. Approximately 6.1% of the company's stock are sold short. View Athene's Current Options Chain.

Some companies that are related to Athene include HANNOVER RUECK/S (HVRRY), AVIVA PLC/ADR (AVVIY), Legal & General Group (LGEN), SONY FINL HOLDI/ADR (SNYFY), AEGON (AEG), Globe Life (GL), Reinsurance Group of America (RGA), Lincoln National (LNC), Voya Financial (VOYA), AMP (AMP), Scor (SCRYY), Primerica (PRI), FGL (FG), Brighthouse Financial (BHF) and Genworth Financial (GNW).

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include JD.Com (JD), AbbVie (ABBV), Alibaba Group (BABA), AT&T (T), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX), Okta (OKTA), Carnival (CCL) and Advanced Micro Devices (AMD).

(ATH) raised $952 million in an IPO on Friday, December 9th 2016. The company issued 23,800,000 shares at a price of $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Athene's stock is owned by a variety of institutional and retail investors. Top institutional investors include Polianta Ltd (0.02%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, Hope S Taitz, James Richard Belardi, Lawrence Ruisi, Marc A Beilinson, Martin P Klein and Robert L Borden. View institutional ownership trends for Athene.

ATH stock was purchased by a variety of institutional investors in the last quarter, including Polianta Ltd. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein. View insider buying and selling activity for Athene.

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ATH stock can currently be purchased for approximately $26.60.

Athene has a market capitalization of $4.73 billion and generates $16.26 billion in revenue each year. The insurance provider earns $2.17 billion in net income (profit) each year or $6.94 on an earnings per share basis. Athene employs 1,325 workers across the globe. View additional information about Athene.

The official website for Athene is http://www.athene.com/.

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at 441-279-8400 or via email at [email protected]